Old Web
English
Sign In
Acemap
>
authorDetail
>
Miriam Marshood
Miriam Marshood
Novartis
Medicine
Internal medicine
Neutropenia
Immunology
Cutaneous T-cell lymphoma
3
Papers
156
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial.
2017
Journal of Cardiac Failure
Naoki Sato
Carolyn S.P. Lam
John R. Teerlink
Barry H. Greenberg
Hiroyuki Tsutsui
Byung-Hee Oh
Jian Zhang
Martin P. Lefkowitz
Tsushung A. Hua
Thomas Holbro
Miriam Marshood
Xing Li Wang
Junbo Ge
Show All
Source
Cite
Save
Citations (24)
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trial.
2013
European Journal of Cancer
Madeleine Duvic
Reinhard Dummer
Jürgen C. Becker
Nicolas Poulalhon
Pablo Luis Ortiz Romero
Maria Grazia Bernengo
Celeste Lebbe
Chalid Assaf
Margaret Squier
Denise Williams
Miriam Marshood
Feng Tai
H. Miles Prince
Show All
Source
Cite
Save
Citations (105)
Phase II Trial of Oral Panobinostat (LBH589) in Patients with Refractory Cutaneous T-Cell Lymphoma (CTCL).
2008
Blood
Madeleine Duvic
Jürgen C. Becker
Stéphane Dalle
Francisco Vanaclocha
Maria Grazia Bernengo
Celeste Lebbe
Reinhard Dummer
Samit Hirawat
Lei Zhang
Miriam Marshood
Glen Laird
H. Miles Prince
Show All
Source
Cite
Save
Citations (27)
1
map